Breast Cancer Research and Treatment

, Volume 103, Issue 1, pp 11–21 | Cite as

Male breast cancer: a review of clinical management

  • A. Agrawal
  • A. A. Ayantunde
  • R. Rampaul
  • J. F. R. Robertson
Review Paper

Abstract

Aims

Male breast cancer incidence is 1% of all breast cancers and is increasing. We aim to present an overview of male breast cancer with particular emphasis on clinical management.

Methods

Studies were identified by an online search of literature in the MEDLINE database till June 2006 followed by an extensive review of bibliographies.

Results

Increased risk factors include genetic predisposition as in BRCA2 families; testicular dysfunction due to chromosomal abnormality such as Klinefelter’s syndrome or environmental factors such as chronic heat exposure and radiation. Clinical assessment with biopsy is the hallmark of diagnosis. Earlier presentations are becoming commoner but there are wide geographical differences. Surgical treatment involves simple or modified radical mastectomy along with surgical assessment of the axilla, either via sentinel node biopsy in clinically node-negative disease or axillary sampling/clearance in node-positive disease. Reconstructions for restoring body image have been recently reported. Indications for adjuvant therapies are similar to that in women. For metastatic disease, tamoxifen is still the mainstay for oestrogen receptor positive disease. For oestrogen receptor negative disease, doxorubicin based chemotherapy regimens are used. In addition, the oft neglected psychological aspects of men having a “cancer of women” are increasingly being recognised.

Conclusions

There is, thus, need for further increasing awareness among men to reduce stigma associated with presentation of symptoms related to breast. This should be in addition to stressing to clinicians the ways of earlier detection and tailor-made “gender oriented” treatment of breast cancer in men.

Keywords

Breast cancer Male Aetiology Pathology Treatment 

References

  1. 1.
    Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GH (2004) Breast carcinoma in men: a population based study. Cancer 101(1):51–57PubMedGoogle Scholar
  2. 2.
    Pich A, Margaria E, Chiusa L (2000) Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival. J Clin Oncol 18(16):2948–2956PubMedGoogle Scholar
  3. 3.
    Bernard-Gallon DJ, Dechelotte PJ, Le Corre L et al (2003) Expression of BRCA1 and BRCA2 in male breast cancers and gynecomastias. Anticancer Res 23(1B):661–667PubMedGoogle Scholar
  4. 4.
    Struewing JP, Brody LC, Erdos MR et al (1995) Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet 57:1–7PubMedGoogle Scholar
  5. 5.
    Wooster R, Neuhausen SL, Mangion J et al (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q 12–13. Science 265:2088–2090PubMedGoogle Scholar
  6. 6.
    Thorlacius S, Tryggvadottir L, Olafsdottir GH et al (1995) Linkage to BRCA2 region in hereditary male breast cancer. Lancet 346:544–545PubMedGoogle Scholar
  7. 7.
    Basham VM, Lipscombe JM, Ward JM et al (2002) BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res 4(1):R2. Epub 2001 Nov 21Google Scholar
  8. 8.
    Wolpert N, Warner E, Seminsky MF, Futreal A, Narod SA (2000) Prevalence of BRCA1 and BRCA2 mutations in male breast cancer patients in Canada. Clin Breast Cancer 1(1):57–63 discussion 64-5PubMedGoogle Scholar
  9. 9.
    Woodward AM, Davis TA, Silva AG, Kirk JA, Leary JA (2005) kConFab investigators. Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families. J Med Genet 42(5):e31PubMedGoogle Scholar
  10. 10.
    Tournier I, Paillerets BB, Sobol H et al (2004) Significant contribution of germline BRCA2 rearrangements in male breast cancer families. Cancer Res 64(22):8143–8147PubMedGoogle Scholar
  11. 11.
    Syrjakoski K, Hyytinen ER, Kuukasjarvi T et al (2003) Androgen receptor gene alterations in Finnish male breast cancer. Breast Cancer Res Treat 77(2):167–170PubMedGoogle Scholar
  12. 12.
    Hultborn R, Hanson C, Kopf I et al (1997) Prevalence of Klinefelter’s syndrome in male breast cancer patients. Anticancer Res 17(6D):4293–4297PubMedGoogle Scholar
  13. 13.
    Ballerini P, Recchione C, Cavalleri A et al (1990) Hormones in male breast cancer. Tumori 76:26–28PubMedGoogle Scholar
  14. 14.
    Casagrande JT, Hanisch R, Pike MC et al (1988) A case–control study of male breast cancer. Cancer Res 48:1326–1330PubMedGoogle Scholar
  15. 15.
    Kessler LRS II (1980) Selected aspects of breast cancer etiology and epidemiology. Proc Am Assoc Cancer Res 21:72Google Scholar
  16. 16.
    Thomas DB, Jimenez LM, McTiernan A et al (1992) Breast cancer in men: risk factors with hormonal implications. Am J Epidemiol 135:734–748PubMedGoogle Scholar
  17. 17.
    Sorensen HT, Friis S, Olsen JH et al (1998) Risk of breast cancer in men with liver cirrhosis. Am J Gastroenterol 93(2):231–233PubMedGoogle Scholar
  18. 18.
    Misra SP, Misra V, Dwivedi M (1996) Cancer of the breast in a male cirrhotic: is there an association between the two? Am J Gastroenterol 91(2):380–382PubMedGoogle Scholar
  19. 19.
    Symmers WS (1968) Carcinoma of the breast in transsexual individuals after surgical and hormonal interference with the primary and secondary sexual characteristics. Br Med J 2:83–87PubMedCrossRefGoogle Scholar
  20. 20.
    Pritchard TJ, Pankowsky DA, Crowe JP et al (1988) Breast cancer in male-to-female transsexual: a case report. J Am Med Assoc 259:2278–2280Google Scholar
  21. 21.
    O’Grady WP, McPivin RW (1969) Breast cancer in a man treated with diethylstilbestrol. Arch Path 88:162–165PubMedGoogle Scholar
  22. 22.
    Schlappack OK, Braun O, Maier U (1986) Report of 2 cases of male breast cancer after prolonged estrogen treatment for prostatic carcinoma. Cancer Detect Prev 9:319–322PubMedGoogle Scholar
  23. 23.
    Karamanakos P, Mitsiades CS, Lembessis P et al (2004) Male breast adenocarcinoma in a prostate cancer patient following prolonged anti-androgen monotherapy. Anticancer Res 24(2C):1077–1081PubMedGoogle Scholar
  24. 24.
    Olsson H, Ranstam J (1988) Head trauma and exposure to prolactin elevating drugs as risk factors for male breast cancer. J Natl Cancer Inst 80:679–683PubMedGoogle Scholar
  25. 25.
    Wallace WA, Balsitis M, Harrison BJ (2001) Male breast neoplasia in association with selective serotonin reuptake inhibitor therapy: a report of three cases. Eur J Surg Oncol 27(4):429–431PubMedGoogle Scholar
  26. 26.
    Ewertz M, Holmberg L, Tretli S, Pedersen BV, Kristensen A (2001) Risk factors for male breast cancer—a case–control study from Scandinavia. Acta Oncol 40(4):467–471PubMedGoogle Scholar
  27. 27.
    Mabuchi K, Bross DS, Kessler II (1985) Risk factors in male breast cancer. J Natl Cancer Inst 74:371–375PubMedGoogle Scholar
  28. 28.
    Cocco P, Figgs L, Dosemeci M et al (1998) Case–control study of occupational exposures and male breast cancer. Occup Environ Med 55(9):599–604PubMedGoogle Scholar
  29. 29.
    Koc M, Polat P (2001) Epidemiology and aetiological factors of male breast cancer: a ten years retrospective study in eastern Turkey. Eur J Cancer Prev 10(6):531–534PubMedGoogle Scholar
  30. 30.
    Demers PA, Thomas DB, Rosenblatt KA et al (1991) Occupational exposure to electromagnetic fields and breast cancer in men. Am J Epidemiol 134:340–347PubMedGoogle Scholar
  31. 31.
    Matanoski GM, Breysse PN, Elliot EA (1991) Electromagnetic field exposure and breast cancer. Lancet 337(8743):737PubMedGoogle Scholar
  32. 32.
    Stenlund C, Floderus B (1997) Occupational exposure to magnetic fields in relation to male breast cancer and testicular cancer: a Swedish case–control study. Cancer Causes Control 8(2):184–191PubMedGoogle Scholar
  33. 33.
    Rosenbaum PF, Vena JE, Zielezny MA, Michalek AM (1994) Occupational exposures associated with male breast cancer. Am J Epidemiol 139(1):30–36PubMedGoogle Scholar
  34. 34.
    Carmichael A, Sami AS, Dixon JM (2003) Breast cancer risk among the survivors of atomic bomb and patients exposed to therapeutic ionising radiation. Eur J Surg Oncol 29(5):475–479PubMedGoogle Scholar
  35. 35.
    Crichlow RW (1972) Carcinoma of the male breast. Surg Gynecol Obstet 13:1011–1019Google Scholar
  36. 36.
    Cohen R, Schauer PK (1984) Male breast cancer following repeated fluoroscopy. Am J Med 76:929–930PubMedGoogle Scholar
  37. 37.
    Gordon DJ, Chin KH, Budny PG, Taylor AR (2003) Male breast cancer in World War II aviation: a case report and review. Breast 12(2):156–157PubMedGoogle Scholar
  38. 38.
    Ron E, Ikeda T, Preston DL, Tokuaka S (2005) Male breast cancer incidence among atomic bomb survivors. J Natl Cancer Inst 97:603–605PubMedCrossRefGoogle Scholar
  39. 39.
    Raviglione MC, Graham PE (1987) Breast carcinoma in a man following local trauma. NY State J Med 87:186–187Google Scholar
  40. 40.
    Sasco AJ, Lowenfels AB, Pasker-De Jonc P (1993) Epidemiology of male breast cancer. A meta-analysis of published case–control studies and discussion of selected etiologic factors. Int J Cancer 53:538–549PubMedGoogle Scholar
  41. 41.
    Guenel P, Cyr D, Sabroe S et al (2004) Alcohol drinking may increase risk of breast cancer in men: a European population-based case–control study. Cancer Causes Control 15(6):571–580PubMedGoogle Scholar
  42. 42.
    Stalsberg H, Thomas DB, Rosenblatt KA et al (1993) Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men. Cancer Causes Control 4:143–151PubMedGoogle Scholar
  43. 43.
    Hultborn R, Friberg S, Hultborn KA (1987) Male breast carcinoma. A study of the total material reported to the Swedish Cancer Registry 1958–1967 with respect to clinical and histopathologic parameters. Acta Oncol 26:241–256PubMedGoogle Scholar
  44. 44.
    Hittmair AP, Lininger RA, Tavassoli FA (1998) Ductal carcinoma in situ (DCIS) in the male breast: a morphologic study of 84 cases of pure DCIS and 30 cases of DCIS associated with invasive carcinoma—a preliminary report. Cancer 83:2139–2149PubMedGoogle Scholar
  45. 45.
    Giordano SH, Buzdar AU, Hortobagyi GN (2002) Breast cancer in men. Ann Intern Med 37(8):678–687Google Scholar
  46. 46.
    Anderson WF, Devesa SS (2005) In situ male breast carcinoma in the surveillance, epidemiology, and end results database of the National Cancer Institute. Cancer 104(8):1733–1741PubMedGoogle Scholar
  47. 47.
    Bloom KJ, Govil H, Gattuso P, Reddy V, Francescatti D (2001) Status of HER-2 in male and female breast carcinomas. Am J Surg 82: 389–392Google Scholar
  48. 48.
    Barlund M, Kuukasjarvi T, Syrjakoski K, Auvinen A, Kallioniemi A (2004) Frequent amplification and overexpression of CCNDI in male breast cancer. Int J Cancer 111:968–971PubMedGoogle Scholar
  49. 49.
    Rudlowski C, Friedrichs N, Faridi A et al (2004) Her-2/neu gene amplification and protein expression in primary male breast cancer. Breast Cancer Res Treat 84(3):215–223PubMedGoogle Scholar
  50. 50.
    Ribeiro G (1985) Male breast carcinoma. A review of 301 cases from the Christie Hospital and Holt Radium Institute, Manchester. Br J Cancer 51:115–119PubMedGoogle Scholar
  51. 51.
    Horm JW, Asire AJ, Young JL et al (eds) (1984) SEER Program: Cancer incidence and mortality in the United States 1973–1981. NIH Publication No. 85-1837. Bethesda, Maryland, U.S. Department of Health and Human Services pp 54–55Google Scholar
  52. 52.
    Borgen PI, Wong GY, Vlamis V et al (1992) Current management of male breast cancer: a review of 104 cases. Ann Surg 215:451–459PubMedGoogle Scholar
  53. 53.
    de Perrot M, Deleaval J, Robert J, Spiliopoulos A (2000) Thirty-year experience of surgery for breast carcinoma in men. Eur J Surg 166(12):929–931PubMedGoogle Scholar
  54. 54.
    Donegan WL, Redlich PN, Lang PJ, Gall MT (1998) Carcinoma of the breast in males: a multiinstitutional survey. Cancer 83(3):498–509PubMedGoogle Scholar
  55. 55.
    Willsher PC, Leach IH, Ellis IO et al (1997) Male breast cancer: pathological and immunohistochemical features. A comparison outcome of male breast cancer with female breast cancer. Am J Surg 173(3):185–188PubMedGoogle Scholar
  56. 56.
    Sandler B, Carman C, Perry RR (1994) Cancer of the male breast. Am Surg 60: 816–820PubMedGoogle Scholar
  57. 57.
    Hassan I, Mabogunje O (1995) Cancer of the male breast in Zaria, Nigeria. East Afr Med J 72(7):457–458PubMedGoogle Scholar
  58. 58.
    Shukla NK, Seenu V, Goel AK et al (1996) Male breast cancer: a retrospective study from a regional cancer center in northern India. J Surg Oncol 61(2):143–148PubMedGoogle Scholar
  59. 59.
    Scheike O (1975) Male breast cancer. Acta Pathol Microbiol Scand [A](Suppl 251):3–35Google Scholar
  60. 60.
    Erlichman C, Murphy KC, Elhakim T (1984) Male breast cancer: a 13-year review of 89 patients. J Clin Oncol 2:903–909PubMedGoogle Scholar
  61. 61.
    Treves N, Robbins FG, Amorosos WL (1956) Serous and serosanguineous discharge from the male nipple. Arch Surg 73:310Google Scholar
  62. 62.
    Simmons RM (2002) Male ductal carcinoma in situ presenting as bloody nipple discharge: a case report and literature review. Breast J 8(2):112–114PubMedGoogle Scholar
  63. 63.
    Perez A, Sanchez JL, Colon AL (2003) Pigmented mammary Paget’s disease in a man. Bol Asoc Med P R 95(4):36–39PubMedGoogle Scholar
  64. 64.
    Desai DC, Brennan EJ Jr, Carp NZ (1996) Paget’s disease of the male breast. Am Surg 62(12):1068–1072PubMedGoogle Scholar
  65. 65.
    Crichlow RW, Kaplan EL, Kearney WH (1972) Male mammary cancer. An analysis of 32 cases. Ann Surg 175:489–494PubMedGoogle Scholar
  66. 66.
    Guinee VF, Olsson H, Moller T et al (1993) The prognosis of breast cancer in males: a report of 335 cases. Cancer 71:154–161PubMedGoogle Scholar
  67. 67.
    Lartigua E, El-jabbour JV, Dubray B et al (1994) Male breast carcinoma: a single center report of clinical parameters. Clin Oncol 6:162–166Google Scholar
  68. 68.
    Namba N, Hiraki A, Tabata M et al (2002) Axillary metastasis as the first manifestation of occult breast cancer in a man: a case report. Anticancer Res 22(6B):3611–3613PubMedGoogle Scholar
  69. 69.
    Maculotti L, Gandini F, Pradella P (1996) Bilateral breast carcinoma. 12 years’ experience. Minerva Chir 51(1–2):33–37(Abstract)PubMedGoogle Scholar
  70. 70.
    Heer R, Shrimankar J, Griffith CD (2003) Granulomatous mastitis can mimic breast cancer on clinical, radiological or cytological examination: a cautionary tale. Breast 12(4):283–286PubMedGoogle Scholar
  71. 71.
    Campagnaro EL, Woodside KJ, Xiao SY, Daller JA, Evers BM (2003) Cystosarcoma phyllodes (phyllodes tumor) of the male breast. Surgery 133(6):689–691PubMedGoogle Scholar
  72. 72.
    Spigel JJ, Evans WP, Grant MD et al (2001) Male inflammatory breast cancer. Clin Breast Cancer 2(2):153–155PubMedCrossRefGoogle Scholar
  73. 73.
    Agrawal RS, Agrawal JR, Agrawal BL et al (2003) Some unusual paraneoplastic syndromes. Case 3. Metastatic pulmonary calcification causing hypoxemia in male breast cancer. J Clin Oncol 21(13):2622–2624PubMedGoogle Scholar
  74. 74.
    Nieder C, Jost PJ, Grosu AL, Peschel C, Molls M (2003) Report of a male patient with brain metastases from breast cancer. Breast 12(5):345–347PubMedGoogle Scholar
  75. 75.
    Brenner RJ, Weitzel JN, Hansen N, Boasberg P (2004) Screening-detected breast cancer in a man with BRCA2 mutation: case report. Radiology 230(2):553–555PubMedGoogle Scholar
  76. 76.
    Gunhan-Bilgen I, Bozkaya H, Ustun EE, Memis A (2002) Male breast disease: clinical, mammographic, and ultrasonographic features. Eur J Radiol 43(3):246–255PubMedGoogle Scholar
  77. 77.
    Hanavadi S, Monypenny IJ, Mansel RE (2006) Is mammography overused in male patients? The Breast 15:123–126PubMedGoogle Scholar
  78. 78.
    Ravandi-Kashani F, Hayes TG (1998) Male breast cancer: a review of the literature. Eur J Cancer 34(9):1341–1347PubMedGoogle Scholar
  79. 79.
    Roubidoux MA, Patterson SK (2005) Breast cancer, male. eMedicine. Last Updated: February 2Google Scholar
  80. 80.
    Yang WT, Whitman GJ, Yuen EH, Tse GM, Stelling CB (2001) Sonographic features of primary breast cancer in men. Am J Roentgenol 176(2):413–416Google Scholar
  81. 81.
    Ozdemir A, Oznur II, Vural G et al (1997) Tl-201 scintigraphy, mammography and ultrasonography in the evaluation of palpable and nonpalpable breast lesions: a correlative study. Eur J Radiol 24(2):145–154PubMedGoogle Scholar
  82. 82.
    Detraux P, Benmussa M, Tristant H et al (1983) Breast disease in the male: galactographic evaluation. Radiology 154:605–606Google Scholar
  83. 83.
    Sneige N, Holder PD, Katz RL et al (1993) Fine needle aspiration cytology of the male breast in a cancer center. Diag Cytopathol 9:691–697Google Scholar
  84. 84.
    Salvadori B, Saccozzi R, Manzari A et al (1994) Prognosis of breast cancer in males: an analysis of 170 cases. Eur J Cancer 30A: 930–935PubMedGoogle Scholar
  85. 85.
    Joshi A, Kapila K, Verma K (1999) Fine needle aspiration cytology in the management of male breast masses. Nineteen years of experience. Acta Cytol 43:334–338PubMedGoogle Scholar
  86. 86.
    Mottolese M, Bigotti G, Coli A et al (1991) Potential use of monoclonal antibodies in the diagnostic distinction of gynecomastia from breast carcinoma in men. Am J Clin Pathol 96:233–237PubMedGoogle Scholar
  87. 87.
    Westenend PJ (2003) Core needle biopsy in male breast lesions. J Clin Pathol 56(11):863–865PubMedGoogle Scholar
  88. 88.
    Jaiyesimi IA, Buzdar AU, Sahin AA et al (1992) Carcinoma of the male breast. Ann Intern Med 117:771–777PubMedGoogle Scholar
  89. 89.
    Scheike O (1974) Male breast cancer. Factors influencing prognosis. Br J Cancer 30:261–271PubMedGoogle Scholar
  90. 90.
    Spence RAJ, MacKenzie G, Anderson JR et al (1985) Long-term survival following cancer of the male breast in Northern Ireland. Cancer 55:648–652PubMedGoogle Scholar
  91. 91.
    Margaria E, Chiusa L, Ferrari L, Dal Canton O, Pich A (2000) Therapy and survival in male breast carcinoma: a retrospective analysis of 50 cases. Oncol Rep 7(5):1035–1039PubMedGoogle Scholar
  92. 92.
    Goss PE, Reid C, Pintilie M, Lim R, Miller N (1999) Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955–1996. Cancer 85(3):629–639PubMedGoogle Scholar
  93. 93.
    Cutuli B, Dilhuydy JM, De Lafontan B et al (1997) Ductal carcinoma in situ of the male breast. Analysis of 31 cases. Eur J Cancer 33(1):35–38PubMedGoogle Scholar
  94. 94.
    Port ER, Fey JV, Cody HS 3rd, Borgen PI (2001) Sentinel lymph node biopsy in patients with male breast carcinoma. Cancer 91(2):319–323PubMedGoogle Scholar
  95. 95.
    Cimmino VM, Degnim AC, Sabel MS et al (2004) Efficacy of sentinel lymph node biopsy in male breast cancer. J Surg Oncol 86(2):74–77PubMedGoogle Scholar
  96. 96.
    Albo D, Ames FC, Hunt KK et al (2003) Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy. Breast Cancer Res Treat 77(1):9–14PubMedGoogle Scholar
  97. 97.
    Goyal A, Horgan K, Kissin M et al (2004) ALMANAC Trialists Group. Sentinel lymph node biopsy in male breast cancer patients. Eur J Surg Oncol 30(5):480–483PubMedGoogle Scholar
  98. 98.
    Di Benedetto G, Pierangeli M, Bertani A (1998) Carcinoma of the male breast: an underestimated killer. Plast Reconstr Surg 102(3):696–700PubMedGoogle Scholar
  99. 99.
    Nakao A, Saito S, Naomoto Y, Matsuoka J, Tanaka N (2002) Deltopectoral flap for reconstruction of male breast after radical mastectomy for cancer in a patient on hemodialysis. Anticancer Res 22(4):2477–2479PubMedGoogle Scholar
  100. 100.
    Caglia P, Veroux PF, Cardillo P et al (1998) Carcinoma of the male breast: reconstructive technique. G Chir 19(8–9):358–362(Abstract)PubMedGoogle Scholar
  101. 101.
    Spear SL, Bowen DG (1998) Breast reconstruction in a male with a transverse rectus abdominis flap. Plast Reconstr Surg 102(5):1615–1617PubMedGoogle Scholar
  102. 102.
    Igun GO (2000) Rectus abdominis myocutaneous flap in reconstruction for advanced male breast cancer: case report. Cent Afr J Med 46(5):130–132PubMedGoogle Scholar
  103. 103.
    Danino A, Ichinose M, Yoshimoto S, Kuroki T, Servant JM (1998) External-internal oblique reverse blood supply musculocutaneous flap for chest wall reconstruction. Ann Plast Surg 41(4):430–433PubMedGoogle Scholar
  104. 104.
    Donegan WL, Redlich PN (1996) Breast cancer in men. Surg Clin North Am 76(2):343–363PubMedGoogle Scholar
  105. 105.
    Buzdar AU (2003) Breast cancer in men. Oncology (Huntingt) 17(10):1361–1364, , 1369–1372 (discussion)Google Scholar
  106. 106.
    La Vecchia C, Levi F, Lucchini F (1992) Descriptive epidemiology of male breast cancer in Europe. Int J Cancer 51:62–66PubMedGoogle Scholar
  107. 107.
    Pich A, Margaria E, Chiusa L, Candelaresi G, Dal Canton O (1999) Androgen receptor expression in male breast carcinoma: lack of clinicopathological association. Br J Cancer 79:959–964PubMedGoogle Scholar
  108. 108.
    Ribeiro G, Swindell R (1992) Adjuvant tamoxifen for male breast cancer. Br J Cancer 65:252–254PubMedGoogle Scholar
  109. 109.
    Giordano SH, Perkins GH, Broglio K et al (2005) Adjuvant systemic therapy for male breast carcinoma. Cancer 104(11):2359–2364PubMedGoogle Scholar
  110. 110.
    Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF, Hoctin-Boes G, Houghton J, Locker GY, Tobias JS, ATAC Trialists’ Group (2005) Results of the ATAC (Arimidex, Tamoxifen, alone or in combination) trial after completion of 5 years’ adjuvant treatment for breast cancer. Lancet 365(9453):60–62PubMedGoogle Scholar
  111. 111.
    Nahleh ZA (2006) Hormonal therapy for male breast cancer: a different approach for a different disease. Cancer Treat Rev 32(2):101–105PubMedGoogle Scholar
  112. 112.
    Handesman (2001) Androgen actions and pharmacologic uses. In: Detroit IJ (ed) Endocrinology. WB Saunders, Philadelphia, pp 2232–2242Google Scholar
  113. 113.
    Chung HC, Koh EH, Roh JK et al (1990) Male breast cancer—a 20 year review of 16 cases at Yonsei University. Yonsei Med 31:242–249Google Scholar
  114. 114.
    Kinne DW (1991) Management of male breast cancer. Oncology 5:5–47Google Scholar
  115. 115.
    Robinson R, Montague ED (1982) Treatment results in males with breast cancer. Cancer 49:403–406Google Scholar
  116. 116.
    Gennari R, Curigliano G, Jereczek-Fossa BA et al (2004) Male breast cancer: a special therapeutic problem. Anything new? (Review). Int J Oncol 24(3):663–670PubMedGoogle Scholar
  117. 117.
    Meguerditchian AN, Falardeau M, Martin G (2002) Male breast carcinoma. Can J Surg 45(4):296–302PubMedGoogle Scholar
  118. 118.
    Fogh S, Hirsch A, Goldberg S, Powell S, Kachnic L (2005) Male breast cancer: combined modality therapy improves survival. Proc ASCO. Abstract No. 873Google Scholar
  119. 119.
    Fentiman IS, Fourquet A, Hortobagyi GN (2006) Male breast cancer. Lancet 367:595–604PubMedGoogle Scholar
  120. 120.
    Bagley CS, Wesley MN, Young RC et al (1987) Adjuvant chemotherapy in males with cancer of the breast. Am J Clin Oncol 10:55–60PubMedGoogle Scholar
  121. 121.
    Patel HZ, Buzdar AU, Hortobagyi GN (1989) Role of adjuvant chemotherapy in male breast cancer. Cancer 64:1583–1585PubMedGoogle Scholar
  122. 122.
    Ribeiro GG (1983) Tamoxifen in the treatment of male breast carcinoma. Clin Radiol 34(6):625–628PubMedGoogle Scholar
  123. 123.
    Kantarjian H, Yap HY, Hortobagyi G, Buzdar A, Blumenschein G (1983) Hormonal therapy for metastatic male breast cancer. Arch Intern Med 143(2):237–240PubMedGoogle Scholar
  124. 124.
    Giordano SH, Valero V, Buzdar AU, Hortobagyi GN (2002) Efficacy of anastrozole in male breast cancer. Am J Clin Oncol 25(3):235–237PubMedGoogle Scholar
  125. 125.
    Italiano A, Largillier R, Marcy PY et al (2004) Complete remission obtained with letrozole in a man treated with metastatic breast cancer. Rev Med Int 25:323–324CrossRefGoogle Scholar
  126. 126.
    Zabolotny BP, Zalal CV, Meterissian SH (2004) Successful use of letrozole in male breast cancer: a case report and review of hormonal therapy for male breast cancer. J Surg Oncol 90:26–30Google Scholar
  127. 127.
    http://www.cancer.gov/clinicaltrials/SWOG-S0511Google Scholar
  128. 128.
    Agrawal A, Cheung KL, Robertson JFR (2006) Fulvestrant in advanced male breast cancer. Breast Cancer Res Treat [Epub ahead of print]Google Scholar
  129. 129.
    Griffith H, Muggia FM (1989) Male breast cancer: update on systemic therapy. Rev Endocrine-Related Cancer 31:5–11Google Scholar
  130. 130.
    Feldman LD (1986) Ketoconazole for metastatic male breast cancer. Ann Intern Med 104:123–124PubMedGoogle Scholar
  131. 131.
    Lopez M, Di Lauro L, Lazzaro B et al (1985) Hormonal treatment of disseminated male breast cancer. Oncology 42:345–349PubMedGoogle Scholar
  132. 132.
    Lopez M (1985) Cyproterone acetate in the treatment of metastatic cancer of the male breast. Cancer 55:2334–2336PubMedGoogle Scholar
  133. 133.
    Vorobiof DA, Falkson G (1987) Nasally administered buserelin inducing complete remission of lung metastases in male breast cancer. Cancer 59:688–689PubMedGoogle Scholar
  134. 134.
    Doberauer C, Niederle N, Schmidt CG (1988) Advanced male breast cancer treatment with LHRH analogue buserelin alone or in combination with the anti-androgen flutamide. Cancer 62:474–478PubMedGoogle Scholar
  135. 135.
    Volm MD (2003) Male breast cancer. Curr Treat Options Oncol 4(2):159–164PubMedGoogle Scholar
  136. 136.
    Lopez M, Di Lauro L, Papaldo P et al (1985) Chemotherapy in metastatic male breast cancer. Oncology 42:205–209PubMedGoogle Scholar
  137. 137.
    Rudlowski C, Werner R, Becker AJ et al (2001) Correspondence. N Engl J Med 345:997–998PubMedGoogle Scholar
  138. 138.
    Zakowski SG, Harris C, Krueger N et al (2003) Social barriers to emotional expression and their relations to distress in male and female breast cancer patients. Br J Health Psychol 8(Pt3):271–286PubMedGoogle Scholar
  139. 139.
    Brain K, Williams B, Iredale R, France L, Gray J (2006) Psychological distress in men with breast cancer. J Clin Oncol 24(1):95–101PubMedGoogle Scholar
  140. 140.
    France L, Michie S, Barrett-Lee P et al (2000) Male cancer: a qualitative study of male breast cancer. The Breast 9:343-348PubMedGoogle Scholar
  141. 141.
    Peate I (2001) Caring for men with breast cancer: causes, symptoms and treatment. Br J Nursing 10(15):975–981Google Scholar
  142. 142.
    Williams BG, Iredale R, Brain K et al (2003) The experiences of men with breast cancer: an exploratory focus group study. Br J Cancer 89:1834–1836Google Scholar
  143. 143.
    Auvinen A, Curtis RE, Ron E (2002) Risk of subsequent cancer following breast cancer in men. J Natl Cancer Inst 94(17):1330–1332PubMedGoogle Scholar
  144. 144.
    O’Malley CD, Prehn AW, Shema SJ, Glaser SL (2002) Racial/ethnic differences in survival rates in a population-based series of men with breast carcinoma. Cancer 94(11):2836–2843PubMedGoogle Scholar
  145. 145.
    Yildirim E, Berberoglu U (1998) Male breast cancer: a 22-year experience. Eur J Surg Oncol 24(6):548–552PubMedGoogle Scholar
  146. 146.
    Salvadori B, Saccozzi R, Manzari A et al (1994) Prognosis of breast cancer in males: an analysis of 170 cases. Eur J Cancer 30A(7):930–935PubMedGoogle Scholar
  147. 147.
    El-Tamer MB, Komenaka IK, Troxel A et al (2004) Men with breast cancer have better disease-specific survival than women. Arch Surg 139(10):1079–1082PubMedGoogle Scholar
  148. 148.
    Scott-Conner CEH, Jochimsen PR, Menck HR, Winchester DJ (1999) An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery 126(4):775–781PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2006

Authors and Affiliations

  • A. Agrawal
    • 1
  • A. A. Ayantunde
    • 1
  • R. Rampaul
    • 1
  • J. F. R. Robertson
    • 1
  1. 1.Professorial Unit of Surgery, City HospitalUniversity of NottinghamNottinghamUK

Personalised recommendations